CRISPR/Cas9 targeting HIV-1 regulatory genes inactivates latent proviral DNA and prevents new infection in T cell culture with inhibition of viral escape - Y. Ophinni; M. Inoue; T. Kotaki; M. Kameoka; Y. Hayashi (Elsevier, 2019)